Evidence map›Paper›PMID 34292433›Full record

SynthesisThe international journal of cardiovascular imaging2021

Echocardiographic assessment of the right ventricle in COVID-19: a systematic review.

Simone Ghidini, Alessio Gasperetti, Dario Winterton, Marco Vicenzi, Mattia Busana, Giovanni Pedrazzini, Luigi Biasco, Gregorio Tersalvi

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in The international journal of cardiovascular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Simone Ghidini *Cardiovascular Disease Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Alessio Gasperetti *Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Dario WintertonDepartment of Anesthesia and Intensive Care Medicine, Niguarda Ca' Granda, Milan, Italy.
Marco VicenziCardiovascular Disease Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Mattia BusanaDepartment of Anesthesiology, University Medical Center Göttingen, Göttingen, Germany.
Giovanni PedrazziniDepartment of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland.
Luigi Biasco *Department of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland.
Gregorio Tersalvi *Division of Cardiology, Cardiocentro Ticino Institute, Lugano, Switzerland. tersalvi@gmail.com.ORCID http://orcid.org/0000-0003-1845-1777
Epatocentro Ticino · CHUniversity of Milan · ITASL Roma · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITJohns Hopkins University · USUniversitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac involvement has been frequently reported in COVID-19 as responsible of increased morbidity and mortality. Given the importance of right heart function in acute and chronic respiratory diseases, its assessment in SARS-CoV-2 infected patients may add prognostic accuracy. Transthoracic echocardiography has been proposed to early predict myocardial injury and risk of death in hospitalized patients. This systematic review presents the up-to-date sum of literature regarding right ventricle ultrasound assessment. We evaluated commonly used echocardiographic parameters to assess RV function and discussed their relationship with pathophysiological mechanisms involved in COVID-19. We searched Medline and Embase for studies that used transthoracic echocardiography for right ventricle assessment in patients with COVID-19.

Indexed as

COVID-19Ventricular Dysfunction, RightEchocardiographyHeart VentriclesHumansPredictive Value of TestsSARS-CoV-2EchocardiographyPulmonary hypertensionRight ventricleSARS-CoV-2

Identifiers

PMID34292433
PMCPMC8295549
OpenAlexW3183268879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.